Bristol-Myers Squibb Co
NYSE:BMY
Gross Margin
Bristol-Myers Squibb Co
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 88.8B USD |
| Gross Margin |
76%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 741.6B USD |
| Gross Margin |
79%
|
| Country | DK |
| Market Cap | 3.9T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | JP |
| Market Cap | 82T JPY |
| Gross Margin |
57%
|
| Country | US |
| Market Cap | 348B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 327.1B USD |
| Gross Margin |
74%
|
| Country | UK |
| Market Cap | 189.4B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 182B CHF |
| Gross Margin |
74%
|
| Country | CH |
| Market Cap | 175.9B CHF |
| Gross Margin |
73%
|
Profitability Report
View the profitability report to see the full profitability analysis for Bristol-Myers Squibb Co.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Bristol-Myers Squibb Co's most recent financial statements, the company has Gross Margin of 76.4%.
You don't have any saved screeners yet
